BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 2562220)

  • 21. Mouse vimentin: structural relationship to fos, jun, CREB and tpr.
    Capetanaki Y; Kuisk I; Rothblum K; Starnes S
    Oncogene; 1990 May; 5(5):645-55. PubMed ID: 2140597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Encounters with Fos and Jun on the road to AP-1.
    Abate C; Curran T
    Semin Cancer Biol; 1990 Feb; 1(1):19-26. PubMed ID: 2133107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins.
    Ryseck RP; Bravo R
    Oncogene; 1991 Apr; 6(4):533-42. PubMed ID: 1827665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coupling of folding and DNA-binding in the bZIP domains of Jun-Fos heterodimeric transcription factor.
    Seldeen KL; McDonald CB; Deegan BJ; Farooq A
    Arch Biochem Biophys; 2008 May; 473(1):48-60. PubMed ID: 18316037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
    Ramirez-Carrozzi VR; Kerppola TK
    J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered protein conformation on DNA binding by Fos and Jun.
    Patel L; Abate C; Curran T
    Nature; 1990 Oct; 347(6293):572-5. PubMed ID: 2120592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrity of FOS B leucine zipper is essential for its interaction with JUN proteins.
    Ryseck RP; Kovary K; Bravo R
    Oncogene; 1990 Jul; 5(7):1091-3. PubMed ID: 2115643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Both Jun and Fos contribute to transcription activation by the heterodimer.
    Hirai S; Bourachot B; Yaniv M
    Oncogene; 1990 Jan; 5(1):39-46. PubMed ID: 2108402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterodimer formation between CREB and JUN proteins.
    Benbrook DM; Jones NC
    Oncogene; 1990 Mar; 5(3):295-302. PubMed ID: 2138276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity.
    Chatton B; Bocco JL; Goetz J; Gaire M; Lutz Y; Kedinger C
    Oncogene; 1994 Feb; 9(2):375-85. PubMed ID: 8290251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
    Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
    Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer.
    De Cesare D; Vallone D; Caracciolo A; Sassone-Corsi P; Nerlov C; Verde P
    Oncogene; 1995 Jul; 11(2):365-76. PubMed ID: 7624151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A ubiquitous nuclear protein stimulates the DNA-binding activity of fos and jun indirectly.
    Abate C; Luk D; Curran T
    Cell Growth Differ; 1990 Oct; 1(10):455-62. PubMed ID: 2126189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the leucine zipper in the fos-jun interaction.
    Kouzarides T; Ziff E
    Nature; 1988 Dec; 336(6200):646-51. PubMed ID: 2974122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A yeast transcription assay defines distinct rel and dorsal DNA recognition sequences.
    Kamens J; Brent R
    New Biol; 1991 Oct; 3(10):1005-13. PubMed ID: 1768648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two functionally different regions in Fos are required for the sequence-specific DNA interaction of the Fos/Jun protein complex.
    Neuberg M; Schuermann M; Hunter JB; Müller R
    Nature; 1989 Apr; 338(6216):589-90. PubMed ID: 2494459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The BZLF1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper.
    Kouzarides T; Packham G; Cook A; Farrell PJ
    Oncogene; 1991 Feb; 6(2):195-204. PubMed ID: 1847997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of jun family gene expression by the tumor promoter okadaic acid.
    Schönthal A; Alberts AS; Frost JA; Feramisco JR
    New Biol; 1991 Oct; 3(10):977-86. PubMed ID: 1662987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA-binding activity of Jun is increased through its interaction with Fos.
    Allegretto EA; Smeal T; Angel P; Spiegelman BM; Karin M
    J Cell Biochem; 1990 Apr; 42(4):193-206. PubMed ID: 2111328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.